» Articles » PMID: 3288993

DNA Base Sequence Changes and Sequence Specificity of Bromodeoxyuridine-induced Mutations in Mammalian Cells

Overview
Specialty Science
Date 1988 Jun 1
PMID 3288993
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

By using a shuttle vector system developed in our laboratory, we have carried out studies on the molecular mechanism by which 5-bromodeoxyuridine (BrdUrd) induces mutations in mammalian cells. The target for mutagenesis in these studies was the Escherichia coli gpt gene that was contained within a retroviral shuttle vector and integrated into chromosomal DNA in mouse A9 cells. Shuttle vector-transformed cells expressing the gpt gene were mutagenized with BrdUrd and cells with mutations in the gpt gene were selected. Shuttle vector sequences were recovered from the mutant cells, and the base sequence of the mutant gpt genes was determined. The great majority of the BrdUrd-induced mutations involving single-base changes were found to be G.C----A.T transitions. We have shown that mutagenesis by BrdUrd depends upon perturbation of deoxycytidine metabolism. Thus, the current results suggest that BrdUrd mutagenesis involves mispairing and misincorporation of BrdUrd opposite guanine in DNA, driven by nucleotide pool perturbation caused by BrdUrd and the resulting imbalanced supply of triphosphates available for DNA synthesis. The results also revealed a very high degree of sequence specificity for the BrdUrd mutagenesis. BrdUrd-induced G.C----A.T transitions occurred almost exclusively in sequences with two adjacent guanine residues. Furthermore, in approximately equal to 90% of the cases, the guanine residue involved in mutation was the one in the more 3' position.

Citing Articles

Enhanced polymerase activity permits efficient synthesis by cancer-associated DNA polymerase ϵ variants at low dNTP levels.

Barbari S, Beach A, Markgren J, Parkash V, Moore E, Johansson E Nucleic Acids Res. 2022; 50(14):8023-8040.

PMID: 35822874 PMC: 9371911. DOI: 10.1093/nar/gkac602.


A regulated nucleocytoplasmic shuttle contributes to Bright's function as a transcriptional activator of immunoglobulin genes.

Kim D, Tucker P Mol Cell Biol. 2006; 26(6):2187-201.

PMID: 16507996 PMC: 1430300. DOI: 10.1128/MCB.26.6.2187-2201.2006.


Sequence-directed base mispairing in human oncogenes.

Lall L, Davidson R Mol Cell Biol. 1998; 18(8):4659-69.

PMID: 9671476 PMC: 109052. DOI: 10.1128/MCB.18.8.4659.


The application of 5-bromodeoxyuridine in the management of CNS tumors.

Freese A, ORourke D, Judy K, OConnor M J Neurooncol. 1994; 20(1):81-95.

PMID: 7807187 DOI: 10.1007/BF01057964.


Molecular analysis of ethyl methanesulfonate-induced reversion of a chromosomally integrated mutant shuttle vector gene in mammalian cells.

Greenspan J, Xu F, Davidson R Mol Cell Biol. 1988; 8(10):4185-9.

PMID: 3185546 PMC: 365488. DOI: 10.1128/mcb.8.10.4185-4189.1988.


References
1.
KAUFMAN E, Davidson R . Bromodeoxyuridine mutagenesis in mammalian cells: mutagenesis is independent of the amount of bromouracil in DNA. Proc Natl Acad Sci U S A. 1978; 75(10):4982-6. PMC: 336246. DOI: 10.1073/pnas.75.10.4982. View

2.
LITTLEFIELD J . THREE DEGREES OF GUANYLIC ACID--INOSINIC ACID PYROPHOSPHORYLASE DEFICIENCY IN MOUSE FIBROBLASTS. Nature. 1964; 203:1142-4. DOI: 10.1038/2031142a0. View

3.
Birnboim H, DOLY J . A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res. 1979; 7(6):1513-23. PMC: 342324. DOI: 10.1093/nar/7.6.1513. View

4.
KAUFMAN E, Davidson R . Bromodeoxyuridine mutagenesis in mammalian cells is stimulated by purine deoxyribonucleosides. Somatic Cell Genet. 1979; 5(5):653-63. DOI: 10.1007/BF01542701. View

5.
Davies J, Jimenez A . A new selective agent for eukaryotic cloning vectors. Am J Trop Med Hyg. 1980; 29(5 Suppl):1089-92. DOI: 10.4269/ajtmh.1980.29.1089. View